Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-10001131Phase 4Completed
Phase 4, randomised trial in epilepsy comparing TPM Group with VPA Group (2 arms). Primary endpoints: Time from randomization to treatment failure and Time from randomization to achievement of 12-month remission. Started Jan 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-10001131.